Medical Marijuana subsidiary HempMeds exhibits at SupplySide West 2018

Print Friendly, PDF & Email
SAN DIEGO — Medical Marijuana announced that its subsidiary HempMeds will be exhibiting its line of cannabidiol (CBD) hemp oil products at SupplySide West, taking place in Las Vegas at the Mandalay Bay Resort on November 7-10.

SupplySide West brings together thousands of ingredient buyers and suppliers from the dietary supplement, beverage, personal care, nutrition and cannabis industries. This year’s event will include over 1,300 exhibitors and 16,000 attendees.

“We are delighted to exhibit our line of our award-winning CBD products at this year’s conference,” said HempMeds president Todd Morrow. “We are committed to supplying the highest quality CBD to retailers and wholesalers throughout the U.S. and this event will offer invaluable opportunities to network and expand our reach.”

HempMeds was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. in 2012 — and the first to both make CBD products available in bulk for U.S. consumers and also provide high-quality CBD hemp oil to customers around the world. HempMeds was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay.

“SupplySide West offers an incredible opportunity to meet thousands of industry-leading buyers and suppliers,” said Medical Marijuana, Inc. chief executive officer Dr. Stuart Titus. “HempMeds is known throughout the world for its natural, therapeutic CBD hemp oil, and with The Brightfield Group’s recent findings that the CBD industry nearly doubled between 2017 and 2018 alone, we’re excited to see the many opportunities that are to come.”



Comments are closed.